Epinephrine Market Size, Trends, Drivers, Growth Rate And Future Expansion To 2033

The new report published by The Business Research Company, titled "Epinephrine Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033", delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.

As per the report, the epinephrine market size has grown rapidly in recent years. It will grow from $2.44 billion in 2023 to $2.69 billion in 2024 at a compound annual growth rate (CAGR) of 10.4%. The epinephrine market size is expected to see strong growth in the next few years. It will grow to $3.82 billion in 2028 at a compound annual growth rate (CAGR) of 9.2%.

Download Free Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=9967&type=smp

Respiratory Health Rise Fueling Growth In The Epinephrine Market
The increase in the prevalence of chronic respiratory diseases is expected to propel the growth of the epinephrine market going forward. Chronic respiratory diseases refer to medical condition that affects the lungs and airways of the human body's respiratory system and has the potential to contract an infection or develop a disease, which can lead to a number of complications. Chronic respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD), interstitial lung disease, pulmonary sarcoidosis, and pneumoconiosis are increasing due to the prevalence of air pollution and harmful environmental, occupational, and behavioral inhalation exposures. Epinephrine is a key medication used in the treatment of severe asthma attacks and anaphylactic reactions, which can cause respiratory distress and potentially life-threatening complications. For instance, in September 2023, according to the World Health Organization, a Switzerland-based specialized agency of the United Nations, there were 41 million deaths, which is 74% of those caused by non-communicable diseases (NCDs) or chronic diseases every year globally. There were 17.9 million deaths from cardiovascular diseases, 9.3 million deaths from cancer, 4.1 million deaths from chronic respiratory diseases, and 2.0 million deaths from diabetes. . As the prevalence of chronic respiratory diseases continues to increase, the demand for epinephrine is also expected to grow.

Innovative Solutions With Advancements In Epinephrine Delivery Systems
Product innovation is a key trend gaining popularity in the epinephrine market. Major companies operating in the epinephrine market are involved in developing new and improved advanced products, such as auto-injectors or advanced injections, to improve convenience of consumption and sustain their position in the market. In September 2021, Baxter International Inc., a US-based healthcare company, launched Premix Norepinephrine Bitartrate in 5% Dextrose Injection (norepinephrine) after getting approved by the US Food and Drug Administration (FDA). Norepinephrine bitartrate is a convenient formulation of norepinephrine manufactured by the pharmaceutical company in dosages of 4 mg/250 mL (16 mcg/mL) and 8 mg/250 mL (32 mcg/mL). Adult patients with severe, acute hypotension are prescribed norepinephrine medication to raise blood pressure.

The epinephrine market covered in this report is segmented -

1) By Type: Prefilled Syringe, Auto-injector, Ampoules and Vials
2) By Application: Anaphylaxis, Cardiac Arrest, Superficial Bleeding, Respiratory Disorders, Other Applications
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=9967&type=discount

Major companies operating in the epinephrine market report are ALK-Abelló A/S, Pfizer Inc., Teva Pharmaceutical Industries Ltd., Mylan NV, Amneal Pharmaceuticals Inc., Bausch Health Companies Inc., Abbott Laboratories, Sanofi SA, Viatris Inc., Lincoln Medical Ltd., Kaleo Inc., Gland Pharma Limited, Adamis Pharmaceuticals Corporation, Harvest Pharmaceuticals Inc., Merit Pharmaceutical, Hospira, Inc., Antares Pharma Inc., Bausch & Lomb Incorporated, Novartis AG, Grand Pharma (China) Co. Ltd., Impax Laboratories LLC, Sandoz International GmbH, Tianjin Jinyao Group Co. Ltd., GlaxoSmithKline plc, Amphastar Pharmaceuticals Inc., Par Sterile Products LLC, Amedra Pharmaceuticals LLC, Crossject SA, Halozyme Therapeutics Inc .

Contents of the report:
1. Executive Summary
2. Epinephrine Market Report Structure
3. Epinephrine Market Trends And Strategies
4. Epinephrine Market - Macro Economic Scenario
5. Epinephrine Market Size And Growth
…..
27. Epinephrine Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Explore the report store to make a direct purchase of the report @ https://www.thebusinessresearchcompany.com/report/epinephrine-global-market-report

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.